Short Interest in Carmell Co. (NASDAQ:CTCX) Rises By 688.2%

Carmell Co. (NASDAQ:CTCX) was the recipient of a large increase in short interest in the month of December. As of December 31st, there was short interest totalling 827,600 shares, an increase of 688.2% from the December 15th total of 105,000 shares. Approximately 6.1% of the company’s stock are sold short. Based on an average daily trading volume, of 10,930,000 shares, the days-to-cover ratio is presently 0.1 days.

Institutional Investors Weigh In On Carmell

An institutional investor recently bought a new position in Carmell stock. Warberg Asset Management LLC bought a new position in Carmell Co. (NASDAQ:CTCX) in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 45,000 shares of the company’s stock, valued at approximately $60,000. Warberg Asset Management LLC owned approximately 0.22% of Carmell as of its most recent SEC filing. Institutional investors and hedge funds own 24.22% of the company’s stock.

Carmell Stock Performance

NASDAQ CTCX traded up $0.06 on Tuesday, reaching $0.60. The stock had a trading volume of 687,148 shares, compared to its average volume of 41,704,277. Carmell has a 1 year low of $0.20 and a 1 year high of $4.00. The business has a 50 day moving average price of $0.31 and a 200 day moving average price of $0.61.

Carmell Company Profile

Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products.